Align Technology Inc (ALGN) Return on Investment ROI from the third quarter of 2026 to third quarter of 2025 and for the year 2026, average high and low, overall ranking from Sep 30 2026 to Sep 30 2025 - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Align Technology inc   (NASDAQ: ALGN)


Align Technology Inc's ROI from its third quarter of 2026 to the third quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Align Technology Inc's ROI in the third quarter of 2026?
Align Technology inc achieved a return on average invested assets (ROI) of 11.2 % in its third quarter of 2026, which is below Align Technology Inc's average return on investment, which stands at 20.2%.

ROI has improved compared to 9.55% in the second quarter of 2026, due to net income growth.

Within the Healthcare sector 109 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the second quarter of 2026 from 734 to 825.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Sep 30 2026)
III. Quarter		 (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter
Y / Y Investment Change TTM -1.37 % -2.98 % 2.5 % 6.81 % 7.53 %
Y / Y Net Income Change TTM 29.99 % -5.49 % 37.35 % 86.72 % 226.31 %
Investment (TTM) in Millions 4,519 4,419 4,408 4,228 4,267
Return On Investment (TTM) 11.2 % 9.55 % 9.74 % 9.19 % 8.49 %
ALGN's Overall Ranking # 825 # 734 # 613 # 651 #
Seq. Investment Change TTM 1.45 % -1.87 % -1.22 % 0.29 % -0.2 %
Seq. Net Income Change TTM 18.93 % -3.79 % 4.76 % 8.44 % -13.53 %
Net Income (TTM) in Millions 492 414 430 410 378

ALGN Company Profile >> Back to ALGN Roi Comparisons >> See Annual ALGN Return On Investment



Return On Investment ALGN's Ranking
Within: No.
Industry # 34
Sector # 110
Overall # 825

Return On Investment Statistics
High Average Low
104.82 %
20.2 %
-0.72 %
(Mar 31 2020)   (Mar 31 2013)







Financial Statements
Align Technology Inc's III. Quarter Investments $ 4,519 Millions ALGN's Balance sheet
Align Technology Inc's III. Quarter Income $ 135 Millions Quarterly ALGN's Income Statement
ALGN's Income by Division See ALGN's Income by Division


ALGN Annual Return On Investment (Dec 31 2025)
2025		 (Dec 31 2024)
2024		 (Dec 31 2023)
2023		 (Dec 31 2022)
2022		 (Dec 31 2021)
2021
Total Investments in Millions 4,314 4,177 4,017 4,022 4,018
Y / Y Investment Growth 3.28 % 3.97 % -0.12 % 0.1 % 14.67 %
Net Income in Millions 410 421 445 362 772
Y / Y Net Income Growth -2.61 % -5.32 % 23.09 % -53.17 % -56.53 %
Annual Return On Investment 9.51 % 10.09 % 11.08 % 8.99 % 19.21 %


Annual Roi Comment
In the fiscal year 2025 ROI decreased relative to the previous year to 9.51 %, due to deterioration of net income.

Definition and Formula of Return on Investment

Other ROI Ratios
Medical Equipment & Supplies Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
ALGN's Roi Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for ALGN's Competitors
Subscribers only: Roi for Align Technology Inc's Suppliers
Subscribers only: Return On Investment for ALGN's Customers

Other Ratios
ALGN's Roa ALGN's Inventory Turnover Ratio ALGN's Growth Rates ALGN's Dividend Statistics
ALGN's Profitability Ratios ALGN's Asset Turnover Ratio ALGN's Dividend Growth
ALGN's Roe ALGN's Valuation Ratios ALGN's Financial Strength Ratios ALGN's Dividend Payout Ratio



Companies with similar Return On Investment at Sep 30 2026, within Healthcare Sector ROI
Caredx Inc   30.65 %
Zevra Therapeutics Inc   29.88 %
Qhslab Inc   27.35 %
Acadia Pharmaceuticals Inc   26.89 %
Protalix Biotherapeutics inc   26.06 %
Standard Biotools Inc   23.91 %
Electromed Inc   23.41 %
Iradimed Corporation  22.98 %
Corcept Therapeutics Inc  22.08 %
Resmed Inc   21.10 %
Alector Inc   20.83 %
Chemed Corporation  20.46 %
Halozyme Therapeutics Inc   19.64 %
Pro dex Inc   19.11 %
Dexcom Inc   18.92 %
Illumina Inc   18.74 %
Denali Therapeutics Inc   17.88 %
West Pharmaceutical Services Inc   17.65 %
Healthcare Services Group Inc   17.18 %
Neurocrine Biosciences Inc   16.94 %
Krystal Biotech Inc   16.91 %
Vertex Pharmaceuticals Inc  16.63 %
Sanuwave Health Inc   16.50 %
Intuitive Surgical Inc   16.30 %
Hca Healthcare Inc   15.54 %
Kiniksa Pharmaceuticals International Plc  15.45 %
Amgen Inc   13.64 %
Carlisle Companies Incorporated  13.64 %
Bristol myers Squibb Company  13.59 %
3m Company  13.24 %

Date modified: 2026-11-05T14:33:44+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.